FDA Import Refusal SCS-5010776-6/11/1 — ACCENT PHARMACEUTICALS & DIAGNOSTICS
The FDA refused shipment SCS-5010776-6/11/1 from ACCENT PHARMACEUTICALS & DIAGNOSTICS (India) on Aug 7, 2024. The refused product falls under Drugs and Biologics — MIFEPRISTONE (PROGESTIN). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Aug 7, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 65JDA38 MIFEPRISTONE (PROGESTIN)
- Charges
- 75